Meta-analysis: efficacy of exclusive enteral nutrition as induction therapy on disease activity index, inflammation and growth factors in paediatric Crohn's disease
- PMID: 35748390
- DOI: 10.1111/apt.17109
Meta-analysis: efficacy of exclusive enteral nutrition as induction therapy on disease activity index, inflammation and growth factors in paediatric Crohn's disease
Abstract
Background: There is evidence of inconsistency in sequelae of exclusive enteral nutrition (EEN) as induction therapy in paediatric patients with Crohn's disease (CD).
Aim: To investigate the potential effects of EEN on paediatric Crohn's disease activity index (PCDAI), inflammation and biochemical parameters in paediatric patients with CD.
Methods: We performed a comprehensive systematic search of PubMed/MEDLINE, Web of Science, SCOPUS and Embase until 8 January 2022 regardless of the time of publication or language. Random-effects model was applied to combine the datasets. The main outcomes were analysed through mean difference (MD) and its 95% confidence interval (CI).
Results: Forty six studies met eligibility criteria and were included in the meta-analysis. Pooled findings indicated that PCDAI score (MD of -27.24; 95% CI -31.84 to -22.64), calprotectin (MD of -842.83 mg/kg; CI -1018.24 to -667.42), CRP (pooled MD of -2.36 mg/dl; CI -2.68 to -2.03), and ESR (MD of -21.09 mm/h; CI -23.79 to -18.38), albumin (MD of 0.65 g/dl; CI 0.58 to 0.72), haemoglobin (MD of 1.12 g/dl; CI 0.87 to 1.37), weight (MD of 4.30 kg; CI 3.39 to 5.22), and height (MD of 0.98 cm; CI 0.35 to 1.62) improved significantly with EEN.
Conclusions: Adherence to EEN can have significant, beneficial effects as induction therapy in paediatric patients with CD.
Keywords: Crohn’s Disease; disease activity index; exclusive enteral nutrition; growth factors meta-analysis; paediatric.
© 2022 John Wiley & Sons Ltd.
Comment in
-
Editorial: further support for exclusive enteral nutrition in paediatric Crohn's disease.Aliment Pharmacol Ther. 2022 Sep;56(5):900-901. doi: 10.1111/apt.17135. Aliment Pharmacol Ther. 2022. PMID: 35934851 No abstract available.
-
JPEN Journal Club 74. Regression to the mean.JPEN J Parenter Enteral Nutr. 2023 Jul;47(5):686-688. doi: 10.1002/jpen.2466. Epub 2022 Dec 21. JPEN J Parenter Enteral Nutr. 2023. PMID: 36448092 No abstract available.
References
REFERENCES
-
- Yu Y, Chen K-C, Chen J. Exclusive enteral nutrition versus corticosteroids for treatment of pediatric Crohn's disease: a meta-analysis. World J Pediatr. 2019;15(1):26-36.
-
- Benchimol EI, Bernstein CN, Bitton A, Carroll MW, Singh H, Otley AR, et al. Trends in epidemiology of pediatric inflammatory bowel disease in Canada: distributed network analysis of multiple population-based provincial health administrative databases. Am J Gastroenterol. 2017;112(7):1120-34.
-
- Turunen P, Ashorn M, Auvinen A, Iltanen S, Huhtala H, Kolho K-L. Long-term health outcomes in pediatric inflammatory bowel disease: a population-based study. Inflamm Bowel Dis. 2009;15(1):56-62.
-
- Dulai PS, Siegel CA, Dubinsky MC. Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(13):2927-36.
-
- Gouldthorpe O, Catto-Smith AG, Alex G. Biologics in paediatric Crohn's disease. Gastroenterol Res Pract. 2011;2011:1-10.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous